Differentiation status influences the prognosis for localized prostate cancer. In this issue of Cancer Cell, Mak and coworkers describe a signaling pathway involving estrogen receptor β (ERβ) that governs whether prostate carcinoma cells maintain an epithelial phenotype or undergo epithelial-mesenchymal transition, suggesting that ERβ would have prognostic or therapeutic value
The androgen receptor (AR) signaling pathway is one of the key pathways deregulated in prostate canc...
Prostate cancer (PC) remains a widespread malignancy in men. Since the androgen/androgen receptor (...
Elucidating oncogenic pathways in prostate cancer is an arduous task. In this issue of Cancer Cell, ...
Differentiation status influences the prognosis for localized prostate cancer. In this issue of Canc...
Although androgen receptor (AR) signaling is the main molecular tool regulating growth and function ...
Prostate cancer (PC) is characterised by dependence upon androgen receptor (AR) as its driving oncog...
Background: Owing to the high incidence rate and the lack of effective treatments, androgen-independ...
The recent discovery of the estrogen receptors alpha and beta (ER, ER) and the progesterone receptor...
Background: Prostate is the site of two of the most common diseases in elderly men, BPH and Prostati...
A major challenge in clinical management of prostate cancer (PC) is to limit tumor growth and preven...
Estrogen receptor β (ERβ) was first identified in the rodent prostate and is abundantly expressed in...
Prostate cancer is the commonest, non-cutaneous cancer in men. At present, there is no cure for the ...
Background: It is well known that estrogens regulate cell cycle progression, but the specific contri...
While it is well documented that the mitogenic actions of estrogens are critical in the development ...
Estrogens were once used for the treatment of prostate cancer (PC). They may still be used in variou...
The androgen receptor (AR) signaling pathway is one of the key pathways deregulated in prostate canc...
Prostate cancer (PC) remains a widespread malignancy in men. Since the androgen/androgen receptor (...
Elucidating oncogenic pathways in prostate cancer is an arduous task. In this issue of Cancer Cell, ...
Differentiation status influences the prognosis for localized prostate cancer. In this issue of Canc...
Although androgen receptor (AR) signaling is the main molecular tool regulating growth and function ...
Prostate cancer (PC) is characterised by dependence upon androgen receptor (AR) as its driving oncog...
Background: Owing to the high incidence rate and the lack of effective treatments, androgen-independ...
The recent discovery of the estrogen receptors alpha and beta (ER, ER) and the progesterone receptor...
Background: Prostate is the site of two of the most common diseases in elderly men, BPH and Prostati...
A major challenge in clinical management of prostate cancer (PC) is to limit tumor growth and preven...
Estrogen receptor β (ERβ) was first identified in the rodent prostate and is abundantly expressed in...
Prostate cancer is the commonest, non-cutaneous cancer in men. At present, there is no cure for the ...
Background: It is well known that estrogens regulate cell cycle progression, but the specific contri...
While it is well documented that the mitogenic actions of estrogens are critical in the development ...
Estrogens were once used for the treatment of prostate cancer (PC). They may still be used in variou...
The androgen receptor (AR) signaling pathway is one of the key pathways deregulated in prostate canc...
Prostate cancer (PC) remains a widespread malignancy in men. Since the androgen/androgen receptor (...
Elucidating oncogenic pathways in prostate cancer is an arduous task. In this issue of Cancer Cell, ...
DOI
Add to ORKG